Join to View Full Profile
931 Highland BlvdSte 3130Bozeman, MT 59715
Phone+1 406-414-5070
Fax+1 920-364-3900
Dr. Conkright is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 1999 - 2001
Jacobi Medical Center/Albert Einstein College of MedicineFellowship, Hematology and Medical Oncology, 1997 - 1999
Central University of VenezuelaClass of 1986
Certifications & Licensure
MT State Medical License 2023 - 2026
WI State Medical License 2012 - 2025
KY State Medical License 2002 - 2018
NY State Medical License 2001 - 2018
TN State Medical License 2002 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Publications & Presentations
PubMed
- Reply to The effects of curative-intent cancer therapy on employment, work ability, and work limitationsAmye J. Tevaarwerk, Kris Kwekkeboom, Kevin A. Buhr, Alexandra Dennee, William Conkright
Cancer. 2021-08-15 - 10 citationsResults from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisc...Amye J. Tevaarwerk, Kris Kwekkeboom, Kevin A. Buhr, Alexandra Dennee, William Conkright
Cancer. 2021-03-01 - 161 citationsPhase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule.Heidi Hörig, David S. Lee, William Conkright, Joe Divito, Henry Hasson
Cancer Immunology, Immunotherapy. 2000-11-01
Committees
- co-chair, lung cancer center of excellence 2019 - Present
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
